Canaccord Genuity Group Reiterates “Buy” Rating for Anpario (LON:ANP)

Anpario (LON:ANPGet Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Canaccord Genuity Group in a report released on Thursday, MarketBeat reports. They presently have a GBX 340 ($4.33) target price on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 46.24% from the stock’s previous close.

Separately, Shore Capital reissued a “house stock” rating on shares of Anpario in a research report on Wednesday, January 24th.

View Our Latest Analysis on Anpario

Anpario Price Performance

ANP stock opened at GBX 232.50 ($2.96) on Thursday. Anpario has a 12 month low of GBX 177 ($2.25) and a 12 month high of GBX 280 ($3.56). The company has a current ratio of 10.62, a quick ratio of 5.16 and a debt-to-equity ratio of 0.25. The company has a 50-day moving average price of GBX 241.10 and a 200 day moving average price of GBX 247.43. The stock has a market cap of £47.22 million, a PE ratio of 2,113.64 and a beta of 0.64.

Insider Buying and Selling

In other news, insider Tim Pollock acquired 4,000 shares of Anpario stock in a transaction that occurred on Wednesday, March 20th. The stock was purchased at an average price of GBX 235 ($2.99) per share, for a total transaction of £9,400 ($11,966.90). 21.66% of the stock is currently owned by company insiders.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.